| Product Code: ETC7051988 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Egypt Oncology NGS Market Overview |
3.1 Egypt Country Macro Economic Indicators |
3.2 Egypt Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Egypt Oncology NGS Market - Industry Life Cycle |
3.4 Egypt Oncology NGS Market - Porter's Five Forces |
3.5 Egypt Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Egypt Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Egypt Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 Egypt Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Egypt Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Egypt Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Egypt |
4.2.2 Growing adoption of Next-Generation Sequencing (NGS) technologies in oncology |
4.2.3 Government initiatives to improve healthcare infrastructure and services |
4.3 Market Restraints |
4.3.1 High cost associated with NGS technology and tests |
4.3.2 Limited access to advanced oncology treatments in certain regions of Egypt |
4.3.3 Lack of skilled professionals in the field of oncology NGS |
5 Egypt Oncology NGS Market Trends |
6 Egypt Oncology NGS Market, By Types |
6.1 Egypt Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Egypt Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Egypt Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Egypt Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2 Egypt Oncology NGS Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Egypt Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F |
6.2.3 Egypt Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F |
6.3 Egypt Oncology NGS Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 Egypt Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F |
6.3.3 Egypt Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Egypt Oncology NGS Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Egypt Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.4.3 Egypt Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.4.4 Egypt Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.5 Egypt Oncology NGS Market, By End-use |
6.5.1 Overview and Analysis |
6.5.2 Egypt Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.5.3 Egypt Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.5.4 Egypt Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.5 Egypt Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F |
6.5.6 Egypt Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F |
7 Egypt Oncology NGS Market Import-Export Trade Statistics |
7.1 Egypt Oncology NGS Market Export to Major Countries |
7.2 Egypt Oncology NGS Market Imports from Major Countries |
8 Egypt Oncology NGS Market Key Performance Indicators |
8.1 Number of oncology NGS tests conducted annually in Egypt |
8.2 Rate of adoption of NGS technologies in oncology clinics and hospitals |
8.3 Research and development investment in oncology NGS technologies in Egypt |
9 Egypt Oncology NGS Market - Opportunity Assessment |
9.1 Egypt Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Egypt Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Egypt Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 Egypt Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Egypt Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Egypt Oncology NGS Market - Competitive Landscape |
10.1 Egypt Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Egypt Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here